Clopidogrel loading dose adjustment according to platelet reactivity monitoring in patients carrying the 2C19*2 loss of function polymorphism.
作者:
主题词
急性冠状动脉综合征(Acute Coronary Syndrome);等位基因(Alleles);血管成形术, 气囊, 冠状动脉(Angioplasty, Balloon, Coronary);芳基烃羟化酶类(Aryl Hydrocarbon Hydroxylases);血蛋白质类(Blood Proteins);细胞黏附分子(Cell Adhesion Molecules);DNA(DNA);剂量效应关系, 药物(Dose-Response Relationship, Drug);心电描记术(Electrocardiography);女(雌)性(Female);随访研究(Follow-Up Studies);基因型(Genotype);人类(Humans);男(雄)性(Male);微丝蛋白质类(Microfilament Proteins);中年人(Middle Aged);监测, 生理学(Monitoring, Physiologic);磷蛋白类(Phosphoproteins);血小板活化(Platelet Activation);聚合酶链反应(Polymerase Chain Reaction);多态现象, 遗传(Polymorphism, Genetic);前瞻性研究(Prospective Studies);嘌呤能P2Y受体拮抗剂(Purinergic P2Y Receptor Antagonists);噻氯匹定(Ticlopidine);治疗结果(Treatment Outcome)
DOI
10.1016/j.jacc.2010.07.004
PMID
20708365
发布时间
2018-12-01
- 浏览14
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文